Oral bioavailability of ATP after prolonged administration

Effect of adenosine 5′-triphosphate infusions on the nutritional status and survival of preterminal cancer patients

(2009) Sandra Beijer et al.   ANTI-CANCER DRUGS

Serum uric acid levels in patients with Parkinson's disease: Their relationship to treatment and disease duration

(2009) Elisabeth Andreadou et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Nucleoside Transporter Proteins

(2009) Miriam Molina-Arcas et al.   Current Vascular Pharmacology

Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade

(2008) Gennady G. Yegutkin   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Uric acid administration in patients with acute stroke: a novel approach to neuroprotection

(2008) Sergio Amaro et al.   Expert Review of Neurotherapeutics

Simultaneous determination of adenosine triphosphate and its metabolites in human whole blood by RP-HPLC and UV-detection

(2008) Erik J.C.M. Coolen et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Purinergic signalling and disorders of the central nervous system

(2008) Geoffrey Burnstock   NATURE REVIEWS DRUG DISCOVERY

Treatment adherence and patients’ acceptance of home infusions with adenosine 5′-triphosphate (ATP) in palliative home care

(2008) Sandra Beijer et al.   SUPPORTIVE CARE IN CANCER

Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future

(2008) Nina C Raju et al.   Nature clinical practice. Cardiovascular medicine

Purinergic signalling

(2006) Geoffrey Burnstock   BRITISH JOURNAL OF PHARMACOLOGY